Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats -: Effects of AT1 blockade with losartan

被引:110
作者
Fortuño, MA
Ravassa, S
Etayo, JC
Díez, J
机构
[1] Univ Navarra, Sch Med, Vasc Pathophysiol Unit, E-31080 Pamplona, Spain
[2] Univ Zaragoza, Sch Med, Dept Med, Zaragoza, Spain
关键词
angiotensin II; apoptosis; Bax; Bcl-2; losartan; rats; inbred SHR;
D O I
10.1161/01.HYP.32.2.280
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
An association of increased apoptosis with overactivity of the local angiotensin-converting enzyme has been reported in cells from the left ventricle of adult rats with spontaneous hypertension (SHR). To gain insight into the regulation of cardiac apoptosis in arterial hypertension, we investigated the expression of the proteins Bcl-2 tan inhibitor of apoptosis) and Bax tan inducer of apoptosis) in the left ventricle of 30-week-old normotensive Wistar-Kyoto rats (WKY), SHR, and SHR treated with the angiotensin II type 1 receptor (AT(1)) antagonist losartan (20 mg.kg(-1).d(-1)) during 14 weeks before death. The density of apoptotic cells was assessed by direct immunoperoxidase detection of biotin-labeled deoxyuridin nucleotides. The expression of Bcl-2 and Bax was assessed by Western blot analysis. Compared with WKY, untreated SHR exhibited increased (P<0.05) apoptosis, increased (P<0.01) Bax, and similar Bcl-2. The Bcl-2/Bax ratio tan inverse index of cell susceptibility to apoptosis) was lower (P<0.05) in untreated SHR than in WKY. The chronic administration of losartan was associated with the normalization of apoptosis, Bax expression, and the Bcl-2/Bax ratio in treated SHR. No changes in the expression of Bcl-2 were observed in these rats after treatment. No significant changes in the apoptotic density were observed between treated SHR with normal blood pressure and treated SHR with abnormally high blood pressure at the end of the treatment period. These results suggest that an association exists between increased apoptosis and overexpression of Bax oncoprotein in cells from the left ventricle of adult SHR. Chronic blockade of AT(1) receptors prevents Bax overexpression and normalizes apoptosis in the left ventricle of SHR independently of its hemodynamic effect. On the basis of our findings, it can be proposed that the interaction of angiotensin II with its AT(1) receptors may participate in the stimulation of Bax protein, which in turn renders cells from the left ventricle of SHR more susceptible to apoptosis.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 41 条
  • [21] Liu Y, 1995, LAB INVEST, V73, P771
  • [22] LOVENBERG W, 1987, HYPERTENSION S1, V9, P5
  • [23] REGULATION OF ANGIOTENSIN-II RECEPTORS ON VENTRICULAR MYOCYTES AFTER MYOCARDIAL-INFARCTION IN RATS
    MEGGS, LG
    COUPET, J
    HUANG, H
    CHENG, W
    LI, P
    CAPASSO, JM
    HOMCY, CJ
    ANVERSA, P
    [J]. CIRCULATION RESEARCH, 1993, 72 (06) : 1149 - 1162
  • [24] Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction
    Misao, J
    Hayakawa, Y
    Ohno, M
    Kato, S
    Fujiwara, T
    Fujiwara, H
    [J]. CIRCULATION, 1996, 94 (07) : 1506 - 1512
  • [25] MIYASHITA T, 1995, CELL, V80, P293
  • [26] MIYASHITA T, 1994, ONCOGENE, V9, P1799
  • [27] Apoptosis in myocytes in end-stage heart failure
    Narula, J
    Haider, N
    Virmani, R
    DiSalvo, TG
    Kolodgie, FD
    Hajjar, RJ
    Schmidt, U
    Semigran, MJ
    Dec, GW
    Khaw, BA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (16) : 1182 - 1189
  • [28] MYOCYTE CELLULAR HYPERTROPHY IS RESPONSIBLE FOR VENTRICULAR REMODELING IN THE HYPERTROPHIED HEART OF MIDDLE-AGED INDIVIDUALS IN THE ABSENCE OF CARDIAC-FAILURE
    OLIVETTI, G
    MELISSARI, M
    BALBI, T
    QUAINI, F
    CIGOLA, E
    SONNENBLICK, EH
    ANVERSA, P
    [J]. CARDIOVASCULAR RESEARCH, 1994, 28 (08) : 1199 - 1208
  • [29] OLIVETTI G, 1980, LAB INVEST, V42, P559
  • [30] Apoptosis in the failing human heart
    Olivetti, G
    Abbi, R
    Quaini, F
    Kajstura, J
    Cheng, W
    Nitahara, JA
    Quaini, E
    DiLoreto, C
    Beltrami, CA
    Krajewski, S
    Reed, JC
    Anversa, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) : 1131 - 1141